Tangible Shareholders Equity (Quarterly)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Haemonetics Corporation (HAE) had Tangible Shareholders Equity of $-254.29M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$339.38M
Net Income	$33.01M
Cost of Goods Sold	$136.58M
Gross Profit	$202.80M
Operating Expenses	$281.92M
Operating Income	$57.46M
Non-Operating Income/Expense	$-9.88M
Pre-Tax Income	$47.57M
Normalized Pre-Tax Income	$47.57M
Income after Taxes	$33.01M
Income from Continuous Operations	$33.01M
Consolidated Net Income/Loss	$33.01M
Normalized Income after Taxes	$33.01M
EBIT	$57.46M
EBITDA	$84.57M
Weighted-Average Shares Outstanding (Basic)	45.36M
Weighted-Average Shares Outstanding (Diluted)	45.70M
Earnings per Share (EPS) (Basic)	$0.73
Earnings per Share (EPS) (Diluted)	$0.72
Balance Sheet Financials
Current Assets	$810.83M
Property, Plant, and Equipment	$303.78M
Long-Term Assets	$1.55B
Total Assets	$2.37B
Current Liabilities	$263.24M
Long-Term Debt	$1.17B
Long-Term Liabilities	$1.27B
Total Liabilities	$1.53B
Common Equity	$837.10M
Tangible Shareholders Equity	$-254.29M
Shareholders Equity	$837.10M
Common Shares Outstanding	45.47M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$52.32M
Cash Flow from Investing Activities	$-22.23M
Cash Flow from Financial Activities	$-51.53M
Beginning Cash	$245.44M
End Cash	$223.38M
Increase/Decrease in Cash	$-22.06M
Stock-Based Compensation	$9.31M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.08
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.58
Debt to Equity Ratio	1.40
Gross Margin	59.76%
Operating Margin	16.93%
EBIT Margin	16.93%
EBITDA Margin	--
Pre-Tax Profit Margin	14.02%
Profit Margin	9.73%
Free Cash Flow	$44.65M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.45
Receiveable Turnover	1.57
Days Sales in Receivables	57.30
Return on Equity	3.94%
Return on Tangible Equity	-12.98%
Return on Assets	1.40%
Return on Investments	1.65%
Book Value Per Share	$18.41
Free Cash Flow per Share	$0.98
Operating Cash Flow per Share	$1.14

Data from Zacks Investment Research, Inc.